All articles related to "noncommunicable diseases":

Off the Cuff: Public Health Shortchanged

The country’s public health expenditures are projected to fall to 2.4 percent of total health expenditures by 2023, putting us embarrassingly behind our peers.

Hypertension poorly managed in low- and middle-income countries

For immediate release: July 18, 2019 Boston, MA – Health systems in low- and middle-income countries (LMICs) are poorly prepared for the increasing number of people with high blood pressure, with more than two-thirds of people affected going without treatment, according to…

To understand noncommunicable diseases, researchers look to inflammation 


Is inflammation a root cause of myriad noncommunicable diseases, including Alzheimer’s, cancer, arthritis, and asthma? A June 2019 Harvard Magazine article surveyed the evidence and profiled several researchers who have studied the role inflammation plays in disease formation. A number of researchers…

Metabolism symposium celebrates foundation of life

June 26, 2018 – The Sabri Ülker Center at Harvard T.H Chan School of Public Health kicked off its second symposium on “Metabolism and Life,” with musical performance, art, and lectures from innovative young researchers and Nobel laureates. The symposium, held May…

Molecular Guardians

Gökhan Hotamisligil is on a mission to help us survive our affluence and its attendant cardiometabolic diseases. His prolific laboratory at the Harvard T.H. Chan School of Public Health and Sabri Ülker Center for Nutrient, Genetic, and Metabolic Research has recently generated…

Research Dream Team to focus on multiple myeloma precursors

Lorelei Mucci, associate professor of epidemiology at Harvard T.H. Chan School of Public Health, is among the researchers participating in a new Stand Up To Cancer (SU2C) Dream Team focused on revolutionizing the treatment of multiple myeloma. Stand Up To Cancer announced…

Doctors often underestimate the addictiveness of opioids

Physicians often underestimate the addictiveness of opioids when writing prescriptions for patients, Atul Gawande, professor in the Department of Health Policy and Management at Harvard T.H. Chan School of Public Health and director of Ariadne Labs, said at a forum on “The…